ABT

Abbott Laboratories · USD

Market open US (NYSE / Nasdaq) · 09:30–16:00 · Mon 14:16 · approx

Deep AI analysis (big model)

No deep analysis yet. Portfolio holdings are analysed automatically; for any other stock, click “Request deep AI analysis” above.

About Abbott Laboratories

Abbott Laboratories is a diversified healthcare company that develops and manufactures medical devices, diagnostics, and biopharmaceuticals, primarily focusing on areas such as nutrition, women's health, diabetes management, and cardiovascular care.

HealthcareFinancialsConsumer

Ticker	ABT
Name	Abbott Laboratories
Currency	USD
Sector	Healthcare

Reputation

😎

How liked 50/100

From 0 recent analysed stories — 0 good · 0 bad · 0 neutral. Trend: stable.

Reputation builds as news about this company is analysed.

Price history & forecast

30-day forecast — Linear regression, Holt's exponential smoothing, and drift, plus a news-adjusted consensus (sentiment tilt +0.00). Estimates only, not advice.

Candlestick, volume & news sentiment

…

good bad neutral closed

Open/high/low/close candles with volume beneath; hover for OHLC, change and volume. Dots mark analysed news by sentiment; shaded bands are when the market was closed. Day and Week show intraday detail; Month+ show daily candles. Step through time with ‹ ›.

Forecast accuracy (backtested)

No scored forecasts yet. Every visit records the day's forecast; once those predicted dates pass, this table fills in with how each method actually did (1 snapshot(s) recorded so far, none matured yet).

Technical analysis

BULLISH

62.96

RSI (14)i

88.06

SMA 20i

91.56

SMA 50i

114.72

SMA 200i

-0.39%

1di

-0.19%

1wi

7.42%

1mi

1.61%

30d voli

138.08

52w highi

82.56

52w lowi

-34.38%

from highi

0.03

MACDi

Downtrend (50d below 200d)MACD bullish crossover

Computed from 255 locally-stored price bars.

AI signals

HOLD 80% · long_term 2026-06-08 10:01

The stock has shown a strong upward trend with consecutive closing above previous day's close, indicating bullish momentum. However, the recent price increase of over 10% in one week is quite significant and could be considered as an overreaction to potentially weak underlying fundamentals or market sentiment shifts. Given the lack of recent news impacting the stock, it suggests a possible correction might occur soon, warranting a cautious stance.

qwen2.5:3b

ABT